Opioid receptor binding characteristics of the non-equilibrium μ antagonist, β-funaltrexamine (β-FNA)

This publication has 22 references indexed in Scilit:

• Pharmacological profiles of β-funaltrexamine (β-FNA) and β-chlornaltrexamine (β-CNA) on the mouse vas deferens preparation
  European Journal of Pharmacology, 1982
• CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN
  British Journal of Pharmacology, 1981
• Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain
  European Journal of Pharmacology, 1981
• The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone
  European Journal of Pharmacology, 1981
• The Role of Membrane Lipids in Receptor Mechanisms
  Annual Review of Pharmacology and Toxicology, 1980
• A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities
  Journal of Medicinal Chemistry, 1980
• Endogenous opioid peptides: multiple agonists and receptors
  Nature, 1977
• Stereospecific binding of etorphine in isolated neural cells and in retina determined by a sensitive microassay
  Brain Research, 1976
• ASSESSMENT IN THE GUINEA‐PIG ILEUM AND MOUSE VAS DEFERENS OF BENZOMORPHANS WHICH HAVE STRONG ANTINOCICEPTIVE ACTIVITY BUT DO NOT SUBSTITUTE FOR MORPHINE IN THE DEPENDENT MONKEY
  British Journal of Pharmacology, 1975
• A New Concept on the Mode of Interaction of Narcotic Analgesics with Receptors
  Journal of Medicinal Chemistry, 1965